Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 10, 2003, Pages 4497-4504

  Takita, Hiroyasu ^a   Yoneya, Shin ^a   Gehlbach, Peter L ^b   Duh, Elia J ^b   Wei, Lisa L ^c   Mori, Keisuke ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GenVec   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; PIGMENT EPITHELIUM DERIVED FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE TRANSFER; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RETINA GANGLION CELL; RETINA ISCHEMIA; RETINA NERVE CELL;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL COUNT; CELL SURVIVAL; CYTOPROTECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; IN SITU NICK-END LABELING; NERVE GROWTH FACTORS; PROTEINS; RATS; RATS, INBRED LEW; REPERFUSION INJURY; RETINAL DISEASES; RETINAL GANGLION CELLS; SERPINS;

EID: 0141541786     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0052     Document Type: Article

References (24)

1. Hivert B, Cerruti C, Camu W. Hydrogen peroxide-induced motoneuron apoptosis is prevented by poly ADP ribosyl synthetase inhibitors. Neuroreport. 1998;9:1835-1838.
2. Skaper SD, Floreani M, Negro A, Facci L, Giusti P. Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathway. J Neurochem. 1998;70:1859-1868.
3. Cao W, Tombran-Tink J, Chen W, Mrazek D, Elias R, McGinnis JF. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res. 1999;57:789-800.
4. Klein R, Klein B. Vision disorders in diabetes. In: Group NDD, ed. Diabetes in America. Washington DC: National Institutes of Health; 1995;293-330.
5. Steeele FR, Chader GJ, Johnson LV, Tombran-Tink J. Pigment epithelium-derived factor (PEDF): neurotrophic activity and identification as a unique member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA. 1993;90:1526-1530.
6. Tombran-Tink J, Chader GJ, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res. 1991;53:411-414.
7. Tombran-Tink J, Pawar H, Swaroop A, Rodriguez I, Chader GJ. Localization of the gene for pigment epithelium-derived factor (PEDF) to chromosome 17p13.3 and expression in cultured human retinoblastoma cells. Genomics. 1994;19:266-272.
8. Goliath R, Tombran-Tink J, Rodriguez I, Chader G, Ramesar R, Greenberg J. The gene for PEDF; a retinal growth factor is a prime candidate for retinitis pigmentosa and is tightly linked to the RP13 locus on chromosome 17p13.3. Mol Vis. 1996;2:5.
9. Cayouette M, Smith SB, Becerra SP, Gravel C. Pigment epithelium-derived factor delays the death of photoreceptors in mouse model of inherited retinal degenerations. Neurobiol Dis. 1999;6:523-532.
10. Ogata N, Wang L, Jo N, et al. Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury. Curr Eye Res. 2001;22:245-252.
11. Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2001;42:1646-1652.
12. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245-248.
13. Stellmach V, Crawford SE, Zhou W, Bouck N. Prevention of ischemia-induced retinopathy by the neural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Nat Acad Soc USA. 2001;98:2593-2597.
14. Mori K, Duh E, Gehlbach PL, et al. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol. 2001;188:253-263.
15. Mori K, Gehlbach PL, Yamamoto S, et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:1994-2000.
16. Rasmussen H, Chu KW, Campochiaro PA, et al. Clinical protocol: an open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD). Hum Gene Ther. 2001;12:2029-2032.
17. Brough DE, Lizonova A, Hsu C, Kulesa VA, Kovesdi I. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J Viol. 1996;70:6497-6501.
18. Mori K, Gehlbach P, Ando A, et al. Intraocular adenoviral-mediated gene transfer in proliferative retinopathies. Invest Ophthalmol Vis Sci. 2002;43:1610-1615.
19. Duh EJ, Yang HS, Suzuma I, et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci. 2002;43:821-829.
20. Nishiyama Y, Hayashi N, Murayama K, Mori K, Yoneya S. Apoptotic changes after pressure-induced ischemia-reperfusion injury in the rat retina [in Japanese]. Nippon Ganka Gakkai Zasshi. 1998;102:417-424.
21. Kuroiwa S, Katai N, Shibuki H, et al. Expression of cell cycle-related genes in dying cells in retinal ischemic injury. Invest Ophthalmol Vis Sci. 1998;39:610-617.
22. Yabe T, Wilson D, Schwartz JP. NFκB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J Biol Chem. 2001;276:43313-43319.
23. Bennet J, Maguire AM, Cideciyan AV, et al. Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci USA. 1999;96:9920-9925.
24. Lau D, McGee L, Zou S-Z, et al. Retinal degeneration is slow in transgenic rats by AAV-mediated delivery of FGF-2. Invest Ophthalmol Vis Sci. 2000;41:3622-3633.